IDenta Corp. (IDTA)
USD 0.32
(0.0%)
USD 0.32
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 442.28 Thousand USD | -1.61% |
| 2022 | 449.51 Thousand USD | 8.09% |
| 2021 | 415.85 Thousand USD | 50.46% |
| 2020 | 276.39 Thousand USD | -15.69% |
| 2019 | 327.82 Thousand USD | 40.67% |
| 2018 | 233.04 Thousand USD | 12.96% |
| 2017 | 206.3 Thousand USD | -5.11% |
| 2016 | 217.4 Thousand USD | -32.74% |
| 2015 | 323.24 Thousand USD | -24.75% |
| 2014 | 429.54 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 426.55 Thousand USD | 0.67% |
| 2024 Q1 | 423.71 Thousand USD | -4.2% |
| 2023 Q4 | 442.28 Thousand USD | 6.92% |
| 2023 Q1 | 437.58 Thousand USD | -2.66% |
| 2023 Q2 | 427.52 Thousand USD | -2.3% |
| 2023 FY | 442.28 Thousand USD | -1.61% |
| 2023 Q3 | 413.66 Thousand USD | -3.24% |
| 2022 Q3 | 365.03 Thousand USD | -1.21% |
| 2022 FY | 449.51 Thousand USD | 8.09% |
| 2022 Q1 | 407.21 Thousand USD | -2.08% |
| 2022 Q2 | 369.51 Thousand USD | -9.26% |
| 2022 Q4 | 449.51 Thousand USD | 23.14% |
| 2021 Q1 | 266.53 Thousand USD | -3.57% |
| 2021 FY | 415.85 Thousand USD | 50.46% |
| 2021 Q4 | 415.85 Thousand USD | 51.11% |
| 2021 Q3 | 275.19 Thousand USD | 0.96% |
| 2021 Q2 | 272.58 Thousand USD | 2.27% |
| 2020 Q2 | 326.87 Thousand USD | 2.86% |
| 2020 Q1 | 317.79 Thousand USD | -3.06% |
| 2020 Q3 | 329.25 Thousand USD | 0.73% |
| 2020 FY | 276.39 Thousand USD | -15.69% |
| 2020 Q4 | 276.39 Thousand USD | -16.05% |
| 2019 Q4 | 327.82 Thousand USD | 30.68% |
| 2019 Q1 | 240.49 Thousand USD | 3.19% |
| 2019 Q2 | 244.94 Thousand USD | 1.85% |
| 2019 FY | 327.82 Thousand USD | 40.67% |
| 2019 Q3 | 250.85 Thousand USD | 2.41% |
| 2018 Q2 | 212.67 Thousand USD | -34.04% |
| 2018 FY | 233.04 Thousand USD | 12.96% |
| 2018 Q4 | 233.04 Thousand USD | 18.18% |
| 2018 Q3 | 197.2 Thousand USD | -7.27% |
| 2018 Q1 | 322.42 Thousand USD | 56.28% |
| 2017 FY | 206.3 Thousand USD | -5.11% |
| 2017 Q4 | 206.3 Thousand USD | 0.0% |
| 2016 FY | 217.4 Thousand USD | -32.74% |
| 2015 FY | 323.24 Thousand USD | -24.75% |
| 2014 FY | 429.54 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | -16.697% |
| Arrayit Corporation | 464.19 Thousand USD | 4.72% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | 41.575% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 18644.277% |
| DermTech, Inc. | 1 Million USD | 55.948% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 86.594% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 51.362% |
| iMD Companies, Inc. | 38.31 Thousand USD | -1054.298% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 63.954% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -171.113% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | 43.587% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 118041.6% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | 5.652% |
| PharmChem, Inc. | 391.93 Thousand USD | -12.845% |
| Proteome Sciences plc | 1.06 Million USD | 58.491% |
| Response Genetics, Inc | 133 Thousand USD | -232.542% |
| Rennova Health, Inc. | 242.64 Thousand USD | -82.275% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -498.51% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -362.535% |
| Todos Medical Ltd. | 1.02 Million USD | 56.682% |